West China Journal of Stomatology ›› 2012, Vol. 30 ›› Issue (4): 346-349.doi: 10.3969/j.issn.1000-1182.2012.04.004

Previous Articles     Next Articles

Change of T lymphocyte subsets, interleukin-2 and tumor necrosis factor-α in tumor- bearing mice and patients with oral cancer receiving thermo-chemotherapy

Shi Chunsheng1, Jin Huijun2, Zhao Jun3, Wang Shengzhi2, Mao Zuyi3.   

  1. 1. Dept. of Stomatology, People’s Hospital of Fushan District of Yantai City, Yantai 265500, China; 2. Dept. of Oral and Maxillofacial Surgery, Yantai Yuhuangding Hospital, Qingdao University Medical College, Yantai 264000, China; 3. State Key Laboratory of Oral Diseases, Sichuan University, Chengdu 610041, China
  • Received:2011-08-05 Revised:2012-03-06 Online:2012-08-01 Published:2012-08-01

Abstract:

Objective To investigate the change of T lymphocyte subsets, interleukin(IL)-2 and tumor necrosis factor(TNF)-α in the tumor- bearing mice and patients with oral cancer receiving thermo-chemotherapy, and investigate the correlation among them. Methods After treatments, the expression of lymphocyte transformation index(LTI), IL-2 and TNF-α in the tumor-bearing mice were detected with methyl thiazolyl tetrazolium(MTT), the expression of IL-2 and TNF-α in the patients with oral cancer were detected with MTT, the expression of LTI, CD4+ and CD8+ were detected with 3H-TdR incorporation. Results LTI, IL-2 and TNF-α of thermo-chemotherapy group(HP group) had no significant difference comparing with those of normal mice group(N group)(P>0.05), but which were significantly
higher than those of chemotherapy group(P group) and no treatment group(NT group)(P<0.01). In clinical trials, the expression of LTI, CD4+, CD4+/CD8+, IL-2 and TNF-α on oral cancer patients after thermo-chemotherapy were significantly higher than those before thermo-chemotherapy(P<0.01). Conclusion After thermo-chemotherapy, the expression of LTI, IL-2 and TNF-α of tumor-bearing hosts are significantly improved, there is a significant correlation between IL-2 and T cell.

Key words: thermo-chemotherapy; T lymphocyte subsets; interleukin-2; tumor necrosis factor-&alpha